Association of the triglyceride–glucose index with albuminuria: a systematic review and meta-analysis - Report - MDSpire

Association of the triglyceride–glucose index with albuminuria: a systematic review and meta-analysis

  • By

  • Ying-Yan Li

  • Chun-Feng Deng

  • Yi Zeng

  • Xi Liu

  • July 3, 2026

  • 0 min

Share

Clinical Report: Evaluation of the Relationship Between the Triglyceride-Glucose Index and Albuminuria

Overview

This systematic review and meta-analysis evaluated the association between the triglyceride-glucose (TyG) index and albuminuria.

Background

Albuminuria is a critical early marker of glomerular microvascular injury and is predictive of chronic kidney disease (CKD) progression. Identifying modifiable risk factors associated with albuminuria is essential for early risk stratification and intervention. The TyG index serves as a convenient surrogate for insulin resistance, which is implicated in renal injury.

Data Highlights

Study TypeSample SizeOR (95% CI)
Cross-sectional59,1482.37 (1.26–4.43)
After outlier exclusion59,1481.61 (1.48–1.75)
CohortNot specified1.19 (1.03–1.37)

Key Findings

  • A higher TyG index is significantly associated with albuminuria (OR = 2.37).
  • After excluding an outlier study, the association remained significant (OR = 1.61).
  • Subgroup analyses showed consistent positive correlations across various populations.
  • The sole cohort study indicated an increased risk of new-onset albuminuria with a higher TyG index (HR = 1.19).
  • Publication bias assessments revealed no significant small-study effects after excluding an outlier.

Clinical Implications

Monitoring the TyG index could assist in identifying patients at risk for albuminuria.

Conclusion

Available evidence indicates that elevated TyG index correlates with increased risk of albuminuria across different populations.

Related Resources & Content

  1. BMC Endocrine Disorders, 2026 -- The association between the triglyceride-glucose index and serum uric acid: a systematic review and meta-analysis
  2. The Journal of Clinical Endocrinology & Metabolism, 2026 -- Characterization of Gut Microbiome Profiles and Metabolites Linked to Albuminuria in Individuals with Type 2 Diabetes
  3. Frontiers in Endocrinology, 2026 -- Albuminuria, but not eGFR, tracks diabetic retinopathy severity and retinal ischemia: population-based discovery, clinical replication, and OCTA evidence
  4. Nature Medicine, 2026 -- A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
  5. American Diabetes Association, 2026 -- The American Diabetes Association Releases “Standards of Care in Diabetes—2026”
  6. Frontiers in Endocrinology — Vitamin D deficiency and metabolic disorders increase albuminuria risk in type 2 diabetes (ACR 0.1–300 mg/g): a nomogram-based stratification
  7. KDIGO 2026 Diabetes and CKD Guideline Update Public Review Draft
  8. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  9. A meta-analysis of albuminuria as a surrogate endpoint for kidney failure | Nature Medicine
  10. The American Diabetes Association Releases “Standards of Care in Diabetes—2026” | American Diabetes Association
  11. Frontiers | Association of the triglyceride–glucose index with albuminuria: a systematic review and meta-analysis
  12. Investigating the association between triglyceride-glucose index and risk of chronic kidney disease: A systematic review and meta-analysis - ScienceDirect

Original Source(s)

Related Content